ANNIE SONG: Open Payments
NPI 1013189869 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,211 in 105 payments from 17 companies in 2025. Trend: 2023 $1,182 · 2024 $2,832 · 2025 $2,211
Food & beverage: $2,125Education: $85
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $522 |
| LEO Pharma Inc. | 37 | $518 |
| Incyte Corporation | 8 | $184 |
| Galderma Laboratories, L.P. | 7 | $154 |
| Organon LLC | 5 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $115 |
| ABBVIE INC. | 3 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Amgen Inc. | 3 | $67 |
| GENZYME CORPORATION | 2 | $66 |
Products named: ADBRY, CIBINQO, LITFULO, OPZELURA, DUPIXENT, NEMLUVIO, RINVOQ, Sotyktu.
Industry payments across CA — which companies pay providers there.
